Compare ORMP & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORMP | RDZN |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | 308 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 147.7M |
| IPO Year | 2010 | N/A |
| Metric | ORMP | RDZN |
|---|---|---|
| Price | $4.66 | $1.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 158.2K | ★ 784.6K |
| Earning Date | 05-14-2026 | 02-12-2026 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | $33.77 |
| Revenue Next Year | N/A | $51.46 |
| P/E Ratio | $3.13 | ★ N/A |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $0.81 |
| 52 Week High | $5.01 | $2.56 |
| Indicator | ORMP | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 69.57 | 55.96 |
| Support Level | $3.21 | $1.69 |
| Resistance Level | N/A | $1.95 |
| Average True Range (ATR) | 0.22 | 0.25 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 68.64 | 37.35 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.